Boehringer wins contract to make Servier’s gevokizumab
August 7, 2012Manufacturing and Production Boehringer Ingelheim, CMO, Servier, antibody
Boehringer Ingelheim’s contract manufacturing organisation (CMO) division will provide commercial-scale manufacturing of a new monoclonal antibody developed by Servier and …
AstraZeneca launches prostate cancer app
August 7, 2012Medical Communications AZ, AstraZeneca, PSA, Zoladex, diabetes, prostate
AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the …
Horizon Discovery appoints chief financial officer
August 7, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Horizon Discovery, Richard Vellacott
Horizon Discovery has announced the appointment of Richard Vellacott as chief financial officer. The firm which is a provider of …
What Does E-Detailing Entail? How E-Detailing is Shaping the Pharmaceutical Industry
August 7, 2012Sales and Marketing e-detailing, sales, sales reps
E-detailing has come at a time of great change in the pharmaceutical industry. The economic recession hit hard with pressure …
Pfizer/Janssen Alzheimer’s drug dropped after failure
August 7, 2012Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab
Pfizer and Janssen have decided to drop their investigational Alzheimer’s drug bapineuzumab after it failed a second late-stage study. The …
Opposition mounting to EU’s API import regulations
August 7, 2012Manufacturing and Production API, EU, TBT, WTO, manufacturing
Changes to the EU’s rules governing the importation of active pharmaceutical ingredients (APIs) are being opposed by the governments of …
Merck’s Singulair faces generic rivals
August 7, 2012Sales and Marketing Merck, Singulair, generic erosion, patent
Merck has lost patent protection on its biggest selling drug Singulair, opening the floodgates for generic rivals. Merck’s drug brought …
Whitehead to GPs: don’t squeeze the drugs budget
August 7, 2012Medical Communications, Sales and Marketing ABPI, CCGs, GPs, NHS, PCTs, reform
GPs should value the drug industry and not seek to squeeze the drugs bill as their predecessors have done, says …
Sue NHS to ensure access to drugs, says NICE chief
August 6, 2012Lucentis, NICE, Ozurdex, judicial review, market access, ophthamology
The chairman of NICE is advising campaigners to sue NHS bodies that block a treatment recommended by the watchdog.In a …
Novartis and Pennsylvania team up on cancer research
August 6, 2012Research and Development Cancer, Novartis, University of Pennsylvania, chimeric antigen receptor
Novartis and the University of Pennsylvania have joined forces to investigate a method of treating cancer which encourages patients’ immune …
Sanofi’s colorectal cancer drug gains FDA approval
August 6, 2012Sales and Marketing FDA, Sanofi, Zaltrap, colorectal cancer
The FDA has approved Sanofi and Regeneron’s new oncology drug Zaltrap for aggressive forms of colorectal cancer.Zaltrap (ziv-aflibercept), in combination …
Talentmark appoints director of Managed Services
August 3, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ian Broadway, Talentmark
Life sciences recruitment firm Talentmark has appointed Ian Broadway as director of Managed Services. Broadway is an experienced life science …
ABPI outlines vision for drug pricing reform
August 3, 2012Sales and Marketing ABPI, NICE, PPRS, VBP, Whitehead, value-based pricing
The ABPI has set out what it wants to see from the new drug pricing system in the UK. Negotiations …
GSK submits melanoma drugs for regulatory approval
August 3, 2012Sales and Marketing FDA, GSK, NDA, Zelboraf, melanoma, oncology
GlaxoSmithKline has submitted its two investigational melanoma drugs to regulators in both Europe and the US. The firm is seeking …
Government healthcare fund pays up
August 3, 2012Research and Development, Sales and Marketing ABPI, MRC, SMEs, government
A £180 million government fund to help small businesses and academics come up with healthcare solutions has made its first …
Teva makes two senior executive appointments
August 3, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Aharon (Arik) Yaari, Carlo De Notaristefani, Teva
Teva has announced the appointments of Dr Carlo De Notaristefani as president and chief executive of Global Operations, and Aharon …
Susan Thiele appointed US head of healthcare
August 3, 2012Medical Communications Hill+Knowlton, susan thiele
Communications firm Hill+Knowlton Strategies has announced the appointment of Susan Thiele as US healthcare practice leader. Thiele has been with …
Pfizer Sandwich site sold to private consortium
August 3, 2012Business Services, Research and Development, Sales and Marketing Jobs, Pfizer, R&D, Sandwich, cuts
The Sandwich Discovery Park in Kent has found new owners, 18 months after Pfizer decided to pull out from the …
Shire posts strong quarter results
August 2, 2012Sales and Marketing ADHD, Adderall XR, Pfizer, Q2, Shire, results
Shire has posted a set of healthy financials for the second quarter, buoyed by its ADHD and rare drug portfolio. …
Bristol-Myers Squibb halts Hep C pill study
August 2, 2012Research and Development, Sales and Marketing BMS, hepatitis C, pill, trial suspension
Bristol-Myers Squibb has halted a mid-stage trial of a new Hepatitis C drug due to major safety concerns. In a …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
